People
-
The Medicon Valley Inhalation Consortium (MVIC) announced that marketing specialist Mats Håkansson will take over the CEO role from Lars Asking. According to the announcement, Asking, who had served as the CEO of MVIC since 2017,… Read more . . .
-
Nocion Therapeutics, whose taplucainium (NTX-1175) DPI is in Phase 2 development for the treatment of chronic cough, has announced the appointments of two former Bellus Health executives, naming Catherine Bonuccelli to the scientific advisory board… Read more . . .
-
Cardiff Scintigraphics, has announced the appointment of OINDP expert John Pritchard as the company’s Chairman of the Board, succeeding David Owen. The news comes soon after Cardiff Scintigraphics, the parent company of inhalation CRO i2c… Read more . . .
-
Disposable dry powder inhaler developer 1nhaler has announced the appointment of former AstraZeneca VP Jane Gaddum as Board Chair and non-executive director and former GSK VP Gordon Muirhead as a non-executive director. Gaddum was AstraZeneca… Read more . . .
-
UK-based Enterprise Therapeutics, which is developing inhaled ENaC blockers for the treatment of cystic fibrosis and other respiratory conditions, has named former Insmed Executive VP of Development and Chief Medical Officer Renu Gupta as the… Read more . . .
-
Cardiff Scintigraphics, the parent company of inhalation CRO i2c Pharma Services, has named former OBG Pharmaceuticals Chief Scientific Officer Andrew Brown as CEO, succeeding Glyn Taylor, who will continue part time as Chief Scientific Officer.… Read more . . .
-
Kindeva Drug Delivery has announced the appointment of Denis Johnson as Chief Operating Officer. Johnson was most recently Head of Global Manufacturing at Biogen and had previously served in executive roles at Catalent Pharma Solutions and Boston… Read more . . .
-
Kindeva Drug Delivery has named former West Pharmaceutical Services Senior Director, Business and Technical Operations, Jennifer Riter as VP of Analytical Services. Earlier this year, Kindeva announced the launch of its new analytical services business, which… Read more . . .
-
Vast Therapeutics has announced the appointments of former Aradigm Senior Medical Director Paul Bruinenberg as Chief Medical Officer and Chris Polage as Medical Director in preparation for clinical development of its ALX1 inhalation solution. Bruinenberg was most recently… Read more . . .
-
Oragenics, which describes itself as “a company focused on developing unique, intranasal nanoparticle pharmaceuticals for the treatment of neurological disorders” has announced the resignation of CEO Kimberly Murphy as part of “a mutually agreeable Separation… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden